GAITHERSBURG, Md.--(BUSINESS WIRE)--Beginning December 1, 2007, Bridge Pharmaceuticals, Inc. (Bridge) will offer a new service for obtaining occupational safety studies on compound exposure during chemical manufacture and handling. With faster study turnarounds and flexible data reporting, Bridge will make it easier for companies to guard their employees against chemical exposure hazards.
